Member Info for Hendi2

Its just when people say "its a week on monday" setting expectations that disappoint.
We have no idea how long the process takes to get this through FDA approval or whats involved to do it.

I know with MTFB because it was for a drug, the testing was rigorous and took literally months to even get a meeting with them.

Just because it states its an emergency with special dispensation does not mean its just a rubber stamp with no testing what so ever. If the test states " results in 2hours" and it targets only the corona virus, as this is the reason that everyone is buying surely this must be proven correct?

The FDA result will come when it comes - hopefully next week because in the meantime the virus continues to spread unabated

The CEO said "in about a week" Not definitely a week
So you have a ceo of a tiny pharma company in the UK......and you have the United States of Americas - FDA
Who calls the shots here on time frame eh?

Maybe they have to analyse data undertaken from the tests used so far. They need to know its effective or they could grant someone pushing any test. The FDA approval needs to prove its an effective way to test for Corona

Mare - read at the top left of the page - got it??

CDC - Centre for Disease Control and Prevention - thats the USA government deptartment

I will be very happy if we get back to 110, im back to where i avgd down yesterday morning with no more funds to benefit from the drop - jsut a bit of blue will set me up for the weekend lol

Spent all day yesterday getting annoyed at people with no understanding of business or the added value that this test will bring to the company and the blue chip pharmas who will be ready in the wings to support them in getting these tests out around the world.

The cost the the global economy is HUGE if this continues

Ive now decided, that rather than get annoyed, to use the filter button liberally lol

lovely afternoon ahead

I absolutely do - im hoping thats exactly what is being put into place while they await FDA approval. Roche have everything thats needed to ensure this test is quickly made and distributed worldwide. I think it will be a jv or licencing deal rather than a buy out

Its not the approval thats needed. They need to get the supply chain sorted from manufacture to distribution to initially those with priority needs such as health/hospital workers/ paramedics/ambulance drivers/airport/airline staff who will need testing before and after each work shift or they will become responsible for spreading the virus to patients/customers/community/family

These people are in high risk positions and need to be sure they are safe while helping people.

I read one MF report where they suggested that the Royal mail was a good stock to be in - hahaha after that i could never take them seriously

Banned or shot Jarvy? lol

I think we maybe surprised at 1pm today when the states wakes up. The CNN news is distributed throughout the USA on TV but also globally via internet We may have a few new buyers and ofcause once it gets above £50m, II's can start buying in too so we may see some TR1's

Thats if Roche havent already done a deal with them

I totally agree with you - so either there is a JV/licencing deal with Roche or potential purchase of the IP for the test
Eitherway this is good news

So many on here talking about 1 test per subject, The amounts of test required per person is an avg of 2 then ofcause all health workers/paramedics/airport staff on airlines from China (infact anywhere where the air is recirculated) will need regular testing on a daily basis if not more. The numbers of tests required globally to ensure this virus does to spread is astronomical. Ncyt do not have the funding or resources in terms of manpower/production to serve the demand, They need a blue chip partner....maybe one who is already marketing their test kit

Interesting

Soon changed your tune - money speaks eh?

At present there is no vaccine. That will take years of testing before they allow vaccination of the population.
A friend and I had a conversation last night. People on here talking about "a test" There needs to be 3 tests staggered in time to ensure someone has not been infected, so to cost up single tests is a false assumption, maybe take the median line on this and say 2 tests per subject.
Then there are the health workers around the world. How many times a day/week do you think they will need to be tested while working to ensure they are not spreading the virus to patient and to their families and local commmunity.

It is naive to count 1 suspected patient = 1 test, this figure is far higher.

This is true for:
Health workers
Ambulance /paramedics
Airport staff

Each of this demographic will need to be tested multiple times each week to reduce the spread of the virus

Also as someone else has mentioned, there are tests required again as people can become reinfected

I really think everyone should focus on Roche. Why are they supplying ncyt's test rather than their own product? They have two awaiting FDA EUA approval as well but choose to market a competitors product.

The way i see it is that Roche have clout, finance, global customer base. Its in their interest to offer both.

So many on here dont have the intelligence to think out of the box, just x amount of tests at £5 = XX
Not considering the IP value of the product.
When NYCT are FDA approved, im sure they will want a global company like Roche to undertake all the marketing and sales and NCYT can get on with improving the test,to make it faster, cheaper

Lets see

Yet again thats not true

The shareprice had already gone down about 30% before the interview - How can you blame the CEO, what did he actually do wrong? Nothing in my book - sure we saw the same?

I dont really understand why many of you invest?

Do you not realise that is not just the number of orders generated but the IP of this test moving forward. If the strain changes slightly, they can amend the test to cater for any new subsequent strains? So this product will be adding value and turnover to the company for a considerable time - unless they are bought out, which i see as a likely scenario

Today has been brutal for us all. I topped up this morning and watched it all drain away but havent sold.

The FDA is to grant an EUA - EMERGENCY USE AUTHORISATION so the test can be used within the States with a population of 331,002,651 people

Then there is the same for the FDA within China, which has a population of: 1,408,526,449 people.
If a very small percentage of either population need testing, to use a technical term "thats a fook of alot of people"

Also people on here being extremely callous thinking about their own pockets that the company have given away free kits. Dont you realise that this is also a marketing tool to get the product noticed by the PRC and to show just how effective the test can be in reducing the spread of this virus?

Also why would CNN bother to interview some tiny company from the UK, if it wasn't going to be of any interest to the people of America?

I think many of you are extremely short sighted, have very little experience in running a business.
What ive read on here has been nothing less than a feeding frenzy in shark (shorters) infested waters

TBH everyone should have a stiff drink and chill out. Tomorrow is another day.

EUA = Emergency Use Authorization | FDA

https://twitter.com/1USNews/status/1230471551591407617?s=20

Theres talk of a JV or buyout with Roche - to do that they need to be warrant free im told.
There are 3 companies going for FDA approval with corona virus tests and one is us, the other Roche who market our test and another company. Roche are massive and could take out the opposition and strongest competitor for business in the States very easily

Mikey

warrants finished
https://www.investegate.co.uk/novacyt-s-a---ncyt-/rns/final-warrant-exercise-and-issue-of-equity/202002191730065211D/

RNS last night - all warrants are finished